Tertiapin
Tertiapin is a potent and selective inhibitor of the inward-rectifier potassium channels (Kir), specifically Kir1.1 and Kir3.x. It is a peptide that was originally isolated from the venom of the honey bee Apis mellifera.
Structure[edit | edit source]
Tertiapin consists of 21 amino acid residues and has a molecular weight of approximately 2.5 kDa. The peptide has a compact structure stabilized by two disulfide bridges.
Function[edit | edit source]
Tertiapin blocks the Kir1.1 and Kir3.x channels by binding to the pore region of the channel, thereby preventing the flow of potassium ions through the channel. This blockage can affect various physiological processes, including heart rate, insulin secretion, and neuronal excitability.
Clinical significance[edit | edit source]
Due to its ability to selectively inhibit certain Kir channels, tertiapin has potential therapeutic applications. For example, it could be used to treat diseases associated with abnormal Kir channel activity, such as certain types of cardiac arrhythmias, diabetes, and epilepsy.
See also[edit | edit source]
References[edit | edit source]
Tertiapin Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD